Covered recipient · General Payments record
AJAY SHARMA
General Payments · PY2022–2024
$1,838.28
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,073.24 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $253.94 | 2 |
| Lilly USA, LLC | $234.56 | 2 |
| GENZYME CORPORATION | $229.09 | 2 |
| PFIZER INC. | $135.00 | 1 |
| UCB, Inc. | $134.08 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $66.57 | 1 |
| Dermavant Sciences, Inc. | $20.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $66.57 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118227712 | CMS |
| Dermavant Sciences, Inc. | $20.00 | 10/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127932265 | CMS |
| GENZYME CORPORATION | $116.95 | 03/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139752275 | CMS |
| GENZYME CORPORATION | $112.14 | 10/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139752319 | CMS |
| Janssen Biotech, Inc. | $130.01 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078330788 | CMS |
| Janssen Biotech, Inc. | $123.93 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078330705 | CMS |
| Lilly USA, LLC | $125.00 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136006853 | CMS |
| Lilly USA, LLC | $109.56 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136012309 | CMS |
| PFIZER INC. | $135.00 | 10/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131421495 | CMS |
| UCB, Inc. | $134.08 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143393165 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.